Covidien (NYSE: COV) reached a definitive agreement to acquire VNUS Medical Technologies, Inc. (NASDAQ: VNUS) for $29 per share ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE